Polar Capital Holdings PLC Alnylam Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 310,000 shares of ALNY stock, worth $73.2 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

310,000

Previous 285,000 8.77%

Holding current value

$73.2 Million

Previous $69.3 Million 23.13%

% of portfolio

0.52%

Previous 0.42%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $5.85 Million - $7.18 Million	25,000 Added 8.77%	310,000 $85.3 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $7.17 Million - $12.4 Million	50,000 Added 21.28%	285,000 $69.3 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $7.33 Million - $9.91 Million	50,000 Added 27.03%	235,000 $35.1 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $7.57 Million - $9.83 Million	-50,000 Reduced 21.28%	185,000 $35.4 Million
Q2 2023 Dec 13, 2023	SELL	$185.01 - $212.05 $14.2 Million - $16.3 Million	-76,918 Reduced 24.66%	235,000 $44.6 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $14.2 Million - $16.3 Million	-76,918 Reduced 24.66%	235,000 $44.6 Million
Q1 2023 Dec 13, 2023	BUY	$182.66 - $235.53 $14 Million - $18.1 Million	76,918 Added 32.73%	311,918 $62.5 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $2.63 Million - $3.4 Million	14,418 Added 4.85%	311,918 $62.5 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $33.9 Million - $44 Million	182,500 Added 158.7%	297,500 $70.7 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $13.6 Million - $22.8 Million	-98,079 Reduced 46.03%	115,000 $23 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $2.02 Million - $2.84 Million	-16,754 Reduced 7.29%	213,079 $31.1 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $38.9 Million - $53.2 Million	-305,798 Reduced 57.09%	229,833 $37.5 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $1.9 Million - $2.49 Million	11,919 Added 2.28%	535,631 $90.8 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $33.2 Million - $40.6 Million	195,430 Added 59.53%	523,712 $98.9 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $16.7 Million - $23 Million	129,782 Added 65.38%	328,282 $55.7 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $443,905 - $614,915	-3,500 Reduced 1.73%	198,500 $28 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $24.8 Million - $29.7 Million	202,000 New	202,000 $26.3 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Alnylam Pharmaceuticals, Inc. Transaction History